ImmunoVaccine Technologies Receives European Patent Allowance

29-Sep-2005

ImmunoVaccine Technologies Inc. (IVT) announced that it has received a patent allowance from the European patent office for their patent application entitled 'Vaccines with enhanced immune response and methods for their preparation'. The patent number provided to IVT was 01 983 349.0-2402.

All of the claims filed for the patent were allowed following modification of claims 43, 44 and 45. These claims were modified to conform to European patent presentation.

Upon receiving the notification Dr. Warwick Kimmins, President and CEO stated, "The issuance of the European patent complements the US patent protection for our VacciMax(R) vaccine platform technology and is good news for IVT's shareholders and our industry partners."

Other news from the department research and development

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance